Oncopeptides AB 2020 Investor Call - Transformation

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Oncopeptides AB investor call presentation from November 2020, addressing the company's transformation strategy. Led by Chief Executive Officer Marty J. Duvall, the presentation covers oncology-focused pharmaceutical development and commercial initiatives.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

Similar investor_presentations from other companies

Browse all →

Jubilant Ingrevia July 2024 Q1 FY25 Investor Presentation

investor_presentation

34 Pages

Jubilant Ingrevia Limited

Prelude Therapeutics Corporate Presentation 2023

investor_presentation